BCBS Michigan Medical Policy Updates – February 2019

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

February 2019 BCBS Michigan Medical Policy Updates:

• Allergy Testing and Immunotherapy
• Amniotic Membrane and Amniotic Fluid
• Approved Off-Label Drug Usage
• Artificial Intervertebral Disc: Cervical Spine
• Automated Point-of-Care Nerve Conduction Tests
• BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
• Bendeka®(bendamustine hydrochloride injection)
• Biofeedback
• BMT – Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
• BMT – Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS  Syndrome
• Cardiovascular Risk Panels
• Chemosensitivity and Chemoresistance Assay, In Vitro
• Circulating Tumor DNA and Circulating Tumor Cells for
• Computed Tomography to Detect Coronary Artery Calcification
• Computer-Aided Evaluation as an Adjunct to Magnetic
• Continuous Subcutaneous Insulin Infusion (CSII) (Insulin Pumps) and Transdermal Insulin Delivery Systems
• Contraception and Voluntary Sterilization
• Coronary Computed Tomography Angiography with Selective Noninvasive Fractional Flow Reserve (FFRCT)
• Cranial Electrotherapy Stimulation (CES) and Auricular Electrostimulation
• Cryoablation of Peripheral Nerves (e.g., iovera° System)
• Dental Anesthesia
• Dialectical Behavior Therapy
• Dual Energy X-Ray Absorptiometry (DXA) Body Composition Study
• Durable Medical Equipment
• Erwinaze®(asparaginase Erwinia chrysanthemi)
• Eye Movement Desensitization and Reprocessing for Post Traumatic Stress Disorder (PTSD)
• Fecal Calprotectin
• Focal Treatments for Prostate Cancer
• Gastric Electrical Stimulation
• Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
• Genetic Testing – Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
• Genetic Testing for Alpha1-Antitrypsin Deficiency
• Genetic Testing for Bloom Syndrome
• Genetic Testing for CHEK2 Mutations for Breast Cancer
• Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
• Genetic Testing for Myotonic Muscular Dystrophy
• Genetic Testing for Specified Conditions Using Testing Panels
• Genetic Testing-Noninvasive Prenatal Screening For Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
• Genicular Nerve Blocks
• H.P. Acthar®Gel (repository corticotropin injection)
• Hemoglobin A1c Testing Device for Home Use or for Use as a Point-of-Care Device
• Home Cardiorespiratory Monitoring – Pediatric
• Home Monitoring Device for Age-Related Macular Degeneration
• Home Spirometry
• Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies
• Implantable Bone-Conduction and Bone-Anchored Hearing Devices
• Intensity Modulated Radiation Therapy (IMRT) of the Breast and Lung
• Intensity Modulated Radiation Therapy (IMRT): Central Nervous System Tumors
• Intensity-Modulated Radiation Therapy (IMRT) of the Prostate
• Intensity-Modulated Radiation Therapy (IMRT): Abdomen and Pelvis
• Intermittent (72 Hours or Greater) or Continuous Invasive Glucose Monitoring
• Intradialytic Parenteral Nutrition (IDPN)
• Intraocular Lens Implant for Myopia (Nearsightedness)
• Invasive Prenatal (Fetal) Diagnostic Testing
• Kyprolis ®  (carfilzomib)
• Laboratory Tests for Heart and Kidney Transplant Rejection
• Lemtrada ®(alemtuzumab)
• Light Therapy for Vitiligo
• Magnetic Pelvic Floor Stimulation as a Treatment of Urinary Incontinence
• Magnetic Resonance Imaging – Low Field
• Magnetic Resonance Imaging for Detection and Diagnosis of Breast Cancer
• Magnetic Resonance Imaging to Monitor Integrity of Silicone-Gel-Filled Breast Implants
• Magnetic Resonance Neurography (MRN)
• Medical Benefit Oncology Drug Class Policy
• MedicalPolicyDocument?fileId=2139204
• MedicalPolicyDocument?fileId=2139801
• Miscellaneous Genetic and Molecular Diagnostic Tests
• Multi-Biomarker Disease Activity (MBDA) Laboratory Testing (e.g., Vectra DA Blood Test) for Rheumatoid Arthritis
• Myocardial Sympathetic Innervation Imaging
• Myolysis of Uterine Fibroids using Laparoscopic, Percutaneous, or Transcervical Techniques
• Nd: YAG Laser Treatment for Hidradenitis Suppurativa
• Neurofeedback
• Non-Contact Ultrasound Treatment for Wounds
• Occipital Nerve Stimulation
• Ocrevus (ocrelizumab)
• Ophthalmologic Techniques for Evaluating Glaucoma
• Orthoptic Training/Vision Therapy for the Treatment of Vision or Learning Disabilities
• Orthoptic Training/Vision Therapy for the Treatment of Vision or Learning Disabilities
• Pancreas Transplant (Allogeneic)
• Patient-Specific Cutting Guides and Custom Knee Implants
• PCR Panel Testing for Gram-Negative Bacillus Antimicrobial Resistance Genes
• Percutaneous Sacral Augmentation
• Phonophoresis
• Photodynamic Therapy for Choroidal Neovascularization
• Placental and Umbilical Cord Blood as a Source of Stem Cells
• Portrazza™(necitumumab)
• Pregnancy Terminations – Medical and Surgical
• Probuphine ®(buprenorphine)
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Miscellaneous Solid Tumors, Excluding Liver Tumors
• Radiofrequency Ablation of Peripheral Nerves to Treat Pain ,including Coolief Cooled RF
• Radiostereometric Analysis (RSA)
• Reproductive Techniques
• Salivary Testing for Hormone Levels
• Saturation Biopsy for Diagnosis and Staging of Prostate Cancer
• Semi-Implantable and Fully Implantable Middle Ear Hearing Aids
• Serum Markers for the Diagnosis of Inflammatory Bowel Disease
• Spectral Analysis of Prostate Tissue
• Spinraza ®(nusinersen)
• Stem Cell Therapy in the Treatment of Peripheral Artery Disease
• Synagis®( palivizumab)
• Testing-Molecular Analysis for Targeted Therapy of Non-Small-Cell Lung Cancer
• Transcatheter Arterial Chemoembolization of Hepatic Tumors (TACE)
• Transmyocardial (Perventricular) Closure of Ventricular Septal Defects
• Transtympanic Micropressure Applications as a Treatment  of Ménière’s Disease
• Treatment of Hyperhidrosis,Excluding Botulinum
• Tysabri®(natalizumab)
• Urinary Tumor Markers for Bladder Cancer
• Velcade®(bortezomib)
• Vertebral Body Tethering and/or Stapling for Scoliosis
• Vertical Expandable Prosthetic Titanium Rib
• Viscocanalostomy and Canaloplasty
• Voraxaze®(glucarpidase)
• Yondelis®(trabectedin)

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.